These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 17389259)

  • 41. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
    Tsai YH; Wang TW; Wei HJ; Hsu CY; Ho HJ; Chen WH; Young R; Liaw CM; Chao JC
    Br J Nutr; 2013 Jun; 109(12):2190-8. PubMed ID: 23046530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
    Enli Y; Fenkci SM; Fenkci V; Oztekin O
    Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
    Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testosterone is associated with insulin resistance index independently of adiposity in women with polycystic ovary syndrome.
    Luotola K; Piltonen TT; Puurunen J; Morin-Papunen LC; Tapanainen JS
    Gynecol Endocrinol; 2018 Jan; 34(1):40-44. PubMed ID: 28678568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
    Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
    Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40.
    Liang SJ; Hsu CS; Tzeng CR; Chen CH; Hsu MI
    Hum Reprod; 2011 Dec; 26(12):3443-9. PubMed ID: 21926412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free testosterone level correlated with the metabolic abnormalities dependent on central obesity in women with polycystic ovary syndrome.
    Dong Z; Chen X; Li L; Huang J; Yin Q; Yang D
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):355-60. PubMed ID: 22576257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation between androgens and cardiovascular risk factors in a young population.
    Gannagé-Yared MH; Chedid R; Abs L
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):720-5. PubMed ID: 21521259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome.
    Shorakae S; Abell SK; Hiam DS; Lambert EA; Eikelis N; Jona E; Sari CI; Stepto NK; Lambert GW; de Courten B; Teede HJ
    Fertil Steril; 2018 Mar; 109(3):532-539. PubMed ID: 29428305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition.
    Kogure GS; Silva RC; Picchi Ramos FK; Miranda-Furtado CL; Lara LA; Ferriani RA; Dos Reis RM
    Gynecol Endocrinol; 2015 Mar; 31(3):237-42. PubMed ID: 25430509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.
    Baillargeon JP; Carpentier A
    Fertil Steril; 2007 Oct; 88(4):886-93. PubMed ID: 17559844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.